Profound Medical Corp. (TSE:PRN - Get Free Report) shares dropped 2.2% during mid-day trading on Thursday . The stock traded as low as C$9.82 and last traded at C$10.00. Approximately 3,040 shares changed hands during trading, a decline of 48% from the average daily volume of 5,801 shares. The stock had previously closed at C$10.22.
Profound Medical Stock Performance
The business's fifty day moving average price is C$9.95 and its 200-day moving average price is C$10.52. The stock has a market cap of C$203.55 million, a PE ratio of -5.01 and a beta of 0.81. The company has a debt-to-equity ratio of 20.05, a quick ratio of 14.98 and a current ratio of 6.12.
About Profound Medical
(
Get Free Report)
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.
Featured Articles
Before you consider Profound Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Profound Medical wasn't on the list.
While Profound Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
